AG1 pulled back marketing 40% and went all-in on science in 2025. “We invested over $10 million in 4 double-blind randomized placebo-controlled human trials.” Their billboards read: “Please enjoy your randomized double-blind placebo controlled daily health drink.” – @KatColeATL https://t.co/DwS1NYfTaA